AR and obesity due to melanocortin 4 receptor deficiency: Well-designed clinical trials with sufficient statistical power and adequate validation are also in urgent need to elucidate whether obesity and the consumption of unbalanced diets may alter the response to ADT or AR signaling inhibitors and contribute to the acquisition of CR.